Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Igama lomkhiqizo:

    Vorinostat CAS 149647-78-9

  • Ibanga:

    Pharmaceutical grade/Cosmetic grade

  • Izakhiwo:

    impushana emhlophe

  • Ukupakisha:

    25kg/isigubhu

  • I-MOQ:

    1 kilo

  • Isitoreji:Indawo Eyomile Epholile
  • Impilo yeshelufu:iminyaka engu-2


Imininingwane

Omaka

Incazelo Yomkhiqizo

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Isicelo
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Izinzuzo

Sinezimboni eziningi zekhwalithi ephezulu ngokubambisana okujulile, ezingakunikeza ngemikhiqizo yekhwalithi ephezulu namanani ancintisanayo. Futhi singanikeza izaphulelo zokuthenga ngobuningi.Futhi sibambisana nezinkampani eziningi ezichwepheshile zokudlulisa impahla, zingaletha imikhiqizo ngokuphepha nangokushelela ezandleni zakho. Isikhathi sokulethwa cishe yizinsuku ezi-3-20 ngemuva kokuqinisekiswa kwenkokhelo.

 

Ukucaciswa

 

Ukuthumela nokukhokha


 

FAQ

1. Ingabe uyimboni noma inkampani yokuhweba?
Siyimboni ehlanganisa i-comnay kanye nezohwebo, sinikeza isevisi eyodwa-stop.OEM ingamukelwa.

2. Uyawahlinzeka ngamasampula? Ingabe imahhala noma ingeziwe?
Amasampula wamahhala.Imali yesampula yempahla idinga ukukhokhwa eceleni kwakho.

3. Ingabe unazo izitifiketi ezihlobene nokulawulwa kwekhwalithi?
Isitifiketi se-ISO 9001:2008 sokuqinisekisa ikhwalithi.

4. Yini okufanele ngiyinikeze ukuze ngithole ikhotheshini?
I-Pls isazise ngohlobo lomkhiqizo oludingayo, inani le-oda, ikheli kanye nezidingo ezithile. Ikhotheshini izokwenzelwa inkomba yakho ngokuhamba kwesikhathi.

5. Hlobo luni lwendlela yokukhokha olukhethayo? Hlobo luni lwamagama olwamukelwayo?
Imigomo Eyamukelwe Yokulethwa: FOB,CFR,CIF,EXW;
Imali Yokukhokha eyamukelwe:USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Ulimi olukhulunywayo:IsiNgisi.

 

Uma unentshisekelo ngemikhiqizo yethu, ungakhetha ukushiya imininingwane yakho lapha, futhi sizokuthinta maduzane.


Bhala umyalezo wakho lapha futhi usithumelele wona